Lancet子刊:经济条件决定了该病的预后——全球年轻人糖尿病死亡率和趋势分析

2022-03-04 MedSci原创 MedSci原创

联合国和世卫组织已将糖尿病确定为五种优先非传染性疾病(NCDs)之一。

联合国和世卫组织已将糖尿病确定为五种优先非传染性疾病(NCDs)之一。相比之下,急性并发症(即糖尿病酮症酸中毒、高渗性昏迷和严重低血糖)、早发性肾衰竭和急性感染造成的死亡可以通过一系列最基本的核心行动来预防

糖尿病,特别是1型糖尿病T1DM,在较年轻的年龄段,如果有正确的医疗保健和服务,在很大程度上是可以预防的死亡原因。近期,国际糖尿病联盟利用2019年全球疾病和风险因素研究(GBD)的数据,评估全球25岁以下年龄段的糖尿病死亡率和趋势。结果发表在Lancet Diabetes & Endocrinology杂志上。

研究人员使用GBD 2019的估计数据来计算1990年和2019年25岁以下年龄段的国际糖尿病死亡率。使用GBD死因组合模型估计每个地方的死亡率,分析了每10万人口年龄标准化死亡率与社会人口指数(SDI)和全民健康覆盖率(UHC)的关联,并描述了SDI五分位数内的变异性。

2019年,全球25岁以下的人群中有16300例(95%CI 14200-18900)因糖尿病(1型和2型合计)导致的死亡发生。其中,73.7%(68.3-77.4)为T1DM。年龄标准化的死亡率为0.50(0.44-0.58)/10万人,其中15900(97.5%)的死亡发生在低至中高SDI国家。

高SDI五分位数的死亡率为0.13(0.12-0.14)/10万人,中低SDI五分位数为0.60(0.51-0.70)/10万人,而低SDI五分位数为0.71(0.60-0.86)/10万人。在SDI五分位数内,观察到不同国家的比率有很大差异,部分原因是UHC的程度(r2=0-62)。

总的来说,从1990年到2019年,全球所有糖尿病的年龄标准化死亡率下降了17.0%(-28.4至-2.9),如果只考虑1型糖尿病,则下降了21.0%(-33.0至-5.9)。然而,低SDI五分位数的所有糖尿病(-13.6%[-28.4至3.4])和1型糖尿病(-13.6%[-29.3至8.9])的下降幅度最低。

降低25岁以下年龄段的糖尿病死亡率仍然是一个重要的挑战,特别是在低和中低SDI国家。糖尿病的诊断和治疗不足可能是造成这些早期死亡的主要原因,这突出表明迫切需要提供更好的胰岛素和基本的糖尿病教育和护理。

 

参考文献:

Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. https://doi.org/10.1016/S2213-8587(21)00349-1

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1831476, encodeId=989018314e65e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 30 02:42:55 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667578, encodeId=21bb166e578dc, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Wed Jul 06 14:42:55 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200393, encodeId=1e6f12003938e, content=糖尿病年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea422452782, createdName=123facfem81(暂无昵称), createdTime=Mon Mar 07 23:28:48 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199539, encodeId=c2791199539a3, content=讲的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52215463987, createdName=ms4000000701714159, createdTime=Sat Mar 05 02:55:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199390, encodeId=abbd1199390f5, content=糖尿病, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f065689544, createdName=ms8000001451504136, createdTime=Fri Mar 04 15:12:28 CST 2022, time=2022-03-04, status=1, ipAttribution=)]
    2023-01-30 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1831476, encodeId=989018314e65e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 30 02:42:55 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667578, encodeId=21bb166e578dc, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Wed Jul 06 14:42:55 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200393, encodeId=1e6f12003938e, content=糖尿病年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea422452782, createdName=123facfem81(暂无昵称), createdTime=Mon Mar 07 23:28:48 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199539, encodeId=c2791199539a3, content=讲的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52215463987, createdName=ms4000000701714159, createdTime=Sat Mar 05 02:55:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199390, encodeId=abbd1199390f5, content=糖尿病, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f065689544, createdName=ms8000001451504136, createdTime=Fri Mar 04 15:12:28 CST 2022, time=2022-03-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1831476, encodeId=989018314e65e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 30 02:42:55 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667578, encodeId=21bb166e578dc, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Wed Jul 06 14:42:55 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200393, encodeId=1e6f12003938e, content=糖尿病年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea422452782, createdName=123facfem81(暂无昵称), createdTime=Mon Mar 07 23:28:48 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199539, encodeId=c2791199539a3, content=讲的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52215463987, createdName=ms4000000701714159, createdTime=Sat Mar 05 02:55:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199390, encodeId=abbd1199390f5, content=糖尿病, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f065689544, createdName=ms8000001451504136, createdTime=Fri Mar 04 15:12:28 CST 2022, time=2022-03-04, status=1, ipAttribution=)]
    2022-03-07 123facfem81(暂无昵称)

    糖尿病年轻化

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1831476, encodeId=989018314e65e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 30 02:42:55 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667578, encodeId=21bb166e578dc, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Wed Jul 06 14:42:55 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200393, encodeId=1e6f12003938e, content=糖尿病年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea422452782, createdName=123facfem81(暂无昵称), createdTime=Mon Mar 07 23:28:48 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199539, encodeId=c2791199539a3, content=讲的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52215463987, createdName=ms4000000701714159, createdTime=Sat Mar 05 02:55:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199390, encodeId=abbd1199390f5, content=糖尿病, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f065689544, createdName=ms8000001451504136, createdTime=Fri Mar 04 15:12:28 CST 2022, time=2022-03-04, status=1, ipAttribution=)]
    2022-03-05 ms4000000701714159

    讲的很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1831476, encodeId=989018314e65e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jan 30 02:42:55 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667578, encodeId=21bb166e578dc, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Wed Jul 06 14:42:55 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200393, encodeId=1e6f12003938e, content=糖尿病年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea422452782, createdName=123facfem81(暂无昵称), createdTime=Mon Mar 07 23:28:48 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199539, encodeId=c2791199539a3, content=讲的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52215463987, createdName=ms4000000701714159, createdTime=Sat Mar 05 02:55:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199390, encodeId=abbd1199390f5, content=糖尿病, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f065689544, createdName=ms8000001451504136, createdTime=Fri Mar 04 15:12:28 CST 2022, time=2022-03-04, status=1, ipAttribution=)]
    2022-03-04 ms8000001451504136

    糖尿病

    0

相关资讯

Diabetes Care:每天多走2000步,糖尿病发病风险降低12%

对于老年人来说,每天更多的步数与较低的糖尿病发病率有关,而中压强度的步数与较低的糖尿病危险最密切相关。

Science Advances:浙大祝赛勇团队成功建立人胰岛前体细胞高效扩增培养新体系

祝赛勇实验室将人多能干细胞分化为胰岛前体细胞,再进一步分化成胰岛细胞,或可治疗糖尿病。

J Diabetes:访视空腹血糖变异性对糖尿病发展的影响:由胰岛素抵抗介导

糖尿病是全球心血管疾病发病和死亡的重要原因之一,给医疗卫生系统带来了巨大的疾病负担。

EJHF:沙库必曲/缬沙坦与缬沙坦对有或无糖尿病和保留射血分数的心衰患者肾功能的影响

糖尿病与心力衰竭(HF)患者的肾功能下降速度更快有关。与单独使用肾素-血管紧张素系统抑制剂相比,沙库必曲/缬沙坦在更大程度上减轻了糖尿病和心力衰竭患者射血分数降低的肾功能恶化。

Cardiovasc Diabetol:血Asprosin可作为糖尿病患者外周动脉疾病的诊断标志物

循环 Asprosin 水平升高是下肢外周动脉疾病的独立危险因素,可作为诊断标志物

Nature子刊:近33万人的研究发现,抑郁症与心脏病和2型糖尿病有关

抑郁症发生频率较低与冠状动脉疾病风险降低34%、2型糖尿病风险降低33%、房颤风险降低20%有关

拓展阅读

BMJ Open Diabetes Res Care:早期HbA1c升高可预测1型糖尿病患者严重微血管病变的发展

糖化血红蛋白(HbA1c)在20世纪80年代初作为平均血糖的生物标志物。

IVD前沿丨1型糖尿病异质性特征的精确诊断工具

在这篇系统综述中,作者探索并总结了胰岛自身抗体在用于识别疾病表现和进展的证据。研究结果表明,在诊断前应用自身抗体特征,特别是与年龄和遗传风险相关的抗体特征,更能理解T1D进展。

Prim Care Diabetes:从快速血糖监测切换到实时警报的快速血糖监测对1型糖尿病患者低血糖的影响

切换到带警报的瞬时血糖监测系统可以改善1型糖尿病患者的TIR和CV。

BMC Pediatr:运动对1型糖尿病儿童睡眠习惯的影响

经过8周的运动训练,实验组的睡眠习惯有所改善。运动作为一种非药物治疗方法是糖尿病儿童控制血糖和改善睡眠质量的有效途径。

Diabetes Ther:1型糖尿病患者连续血糖监测HbA1c与血糖时间范围的关系

这项描述性研究表明,HbA1c与CGM衍生指标(即范围内时间(TIR)、范围以上时间(TAR)和CGM平均血糖)之间的关联程度在评估临床1型糖尿病患者的管理方面是强有力的。

Nature Medicine:从自动胰岛素输送到全功能人造胰腺:1型糖尿病治疗的突破

全自动人造胰腺的研究和试验正在全球范围内积极进行中,许多研究已经展示了这些系统在提高血糖控制、减少低血糖事件以及改善患者生活质量方面的巨大潜力。